Show simple item record

dc.contributor.authorDe Jong, Hilda J.I.
dc.contributor.authorPrice, David
dc.contributor.authorVoorham, Jaco
dc.contributor.authorScadding, Glenis K
dc.contributor.authorBachert, Claus
dc.contributor.authorCanonica, Giorgio Walter
dc.contributor.authorSmith, Peter
dc.contributor.authorWahn, Ulrich
dc.contributor.authorRyan, Dermot
dc.contributor.authorCastillo, Jose A.
dc.contributor.authorCarter, Victoria A
dc.contributor.authorMurray, Ruth B
dc.contributor.authorPrice, David B
dc.date.accessioned2021-01-06T08:41:01Z
dc.date.available2021-01-06T08:41:01Z
dc.date.issued2020-12
dc.identifier.citationDe Jong , H J I , Price , D , Voorham , J , Scadding , G K , Bachert , C , Canonica , G W , Smith , P , Wahn , U , Ryan , D , Castillo , J A , Carter , V A , Murray , R B & Price , D B 2020 , ' Evaluating the Real-life Effect of MP-AzeFlu On Asthma Outcomes In Patients With Allergic Rhinitis and Asthma In UK Primary Care ' , World Allergy Organization Journal , vol. 13 , no. 12 , 100490 . https://doi.org/10.1016/j.waojou.2020.100490en
dc.identifier.issn1939-4551
dc.identifier.otherPURE: 179049813
dc.identifier.otherPURE UUID: a885cf29-caa4-434f-b0ed-82fb7096236e
dc.identifier.otherScopus: 85099522655
dc.identifier.otherPubMed: 33376573
dc.identifier.urihttps://hdl.handle.net/2164/15588
dc.descriptionThis study was supported by funding from BGP Products Operations GmbH (A MylanCompany). BGP Products Operations GmbH was given the opportunity to review the manuscript for medical and scientific accuracy as well as for intellectual property considerations. The dataset supporting the conclusions of this article was derived from the Optimum Patient Care Research Database (www.opcrd.co.uk). The OPCRD has ethical approval from the National Health Service (NHS) Research Authority to hold and process anonymized research data (Research Ethics Committee reference: 15/EM/0150). This study was approved by the Anonymized Data Ethics Protocols and Transparency (ADEPT) committee – the independent scientific advisory committee for the OPCRD. The authors do not have permission to give public access to the study dataset; researchers may request access to OPCRD data for their own purposes. Access to OCPRD can be made via the OCPRD website (https://opcrd.co.uk/our-database/data-requests/) or via the enquiries email info@opcrd.co.uk.en
dc.format.extent18
dc.language.isoeng
dc.relation.ispartofWorld Allergy Organization Journalen
dc.rightshttps://creativecommons.org/licenses/by/4.0/en
dc.subjectcontrolen
dc.subjectexacerbationsen
dc.subjectrescue medicationen
dc.subjectR Medicineen
dc.subjectSupplementary data availableen
dc.subject.lccRen
dc.titleEvaluating the Real-life Effect of MP-AzeFlu On Asthma Outcomes In Patients With Allergic Rhinitis and Asthma In UK Primary Careen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.waojou.2020.100490


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record